Overview
Edward Walsh is a Radiologist and an Interventional Radiologist in Traverse City, Michigan. Dr. Walsh has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), WT1-Related Wilms Tumor Syndromes, Vertebroplasty, and Bone Graft.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1105 6th St, Traverse City, MI 49684
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Grand Traverse Radiologists PC
William Karczewski is a Radiologist in Traverse City, Michigan. Dr. Karczewski is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Visceromegaly, Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia.
Grand Traverse Radiologists PC
William Allsopp is an Interventional Radiologist and a Radiologist in Traverse City, Michigan. Dr. Allsopp is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Boils, Ascites, Small Cell Lung Cancer (SCLC), Vertebroplasty, and Bone Graft. Dr. Allsopp is currently accepting new patients.
Grand Traverse Radiologists PC
Frederick Brodeur is a Radiologist and an Interventional Radiologist in Traverse City, Michigan. Dr. Brodeur is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Retroperitoneal Fibrosis, Lung Nodules, Intussusception in Children, Bone Graft, and Vertebroplasty. Dr. Brodeur is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AscitesDr. Walsh isAdvanced. Learn about Ascites.
- Familial Pancreatic CancerDr. Walsh isAdvanced. Learn about Familial Pancreatic Cancer.
- Familial Prostate CancerDr. Walsh isAdvanced. Learn about Familial Prostate Cancer.
- Intussusception in ChildrenDr. Walsh isAdvanced. Learn about Intussusception in Children.
- Lung CancerDr. Walsh isAdvanced. Learn about Lung Cancer.
- Muscle Invasive Bladder CancerDr. Walsh isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Walsh isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Adenosine Deaminase 2 DeficiencyDr. Walsh isExperienced. Learn about Adenosine Deaminase 2 Deficiency.
- Alcoholic CirrhosisDr. Walsh isExperienced. Learn about Alcoholic Cirrhosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Ampullary CancerDr. Walsh isExperienced. Learn about Ampullary Cancer.
- Anaplastic Thyroid CancerDr. Walsh isExperienced. Learn about Anaplastic Thyroid Cancer.